Share Price and Basic Stock Data
Last Updated: October 17, 2025, 4:31 am
PEG Ratio | -0.39 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Rana Sugars Ltd operates in the sugar industry and has reported a market capitalization of ₹224 Cr. The company’s sales have shown a fluctuating trend over the past few quarters, with a notable increase in June 2023, reaching ₹499.94 Cr., followed by a decline to ₹340.13 Cr. in September 2023. For the fiscal year ending March 2025, total sales stood at ₹1,713 Cr., up from ₹1,627 Cr. in March 2023, indicating a gradual recovery post-pandemic. The company’s annual sales have seen a compound growth rate, with the latest trailing twelve months (TTM) revenue reported at ₹1,782 Cr. This growth aligns with the overall recovery in the sugar sector, as per industry reports, which have indicated rising demand and improved sugar prices. The operating profit margin (OPM) has been quite variable, recorded at 1.30%, reflecting challenges in cost management amid fluctuating raw material prices.
Profitability and Efficiency Metrics
Rana Sugars Ltd’s profitability metrics reveal a mixed performance. The net profit for the year ending March 2025 was reported at ₹34 Cr., with earnings per share (EPS) at ₹2.24. This is a decline from ₹4.13 in March 2023, indicating a challenging year for profitability. The company’s return on equity (ROE) stood at 5.99%, while return on capital employed (ROCE) was reported at 7.67%, suggesting that capital is being utilized with moderate efficiency. The interest coverage ratio (ICR) is relatively healthy at 3.12x, indicating that the company can comfortably meet its interest obligations. However, the cash conversion cycle (CCC) of 91 days points to potential inefficiencies in inventory management and receivables collection, which could hinder liquidity and operational agility. The overall financial health appears stable, but the company must address its profitability issues to enhance shareholder value.
Balance Sheet Strength and Financial Ratios
The balance sheet of Rana Sugars Ltd reflects a conservative financial structure, with total borrowings reported at ₹435 Cr. against reserves of ₹394 Cr. This results in a debt-to-equity ratio of 0.68x, suggesting a manageable level of leverage. The company’s current ratio stands at 1.12, indicating satisfactory short-term liquidity, while the quick ratio at 0.40 reveals potential challenges in meeting immediate liabilities without relying on inventory liquidation. The book value per share has increased to ₹37.47, improving from ₹33.37 in the previous year, which indicates a strengthening of shareholder equity. The price-to-book value ratio of 0.32x suggests that the stock is trading at a significant discount relative to its net assets, which could attract value-focused investors. However, the declining trend in operating profit and net profit margins raises concerns about the sustainability of this financial structure in the long term.
Shareholding Pattern and Investor Confidence
Rana Sugars Ltd’s shareholding pattern shows a stable structure with promoters holding 22.64% of the equity, while public shareholders constitute a significant 75.66%. Foreign institutional investors (FIIs) represent a minimal 0.04%, and domestic institutional investors (DIIs) hold none, indicating a lack of institutional interest. The number of shareholders has increased to 1,24,133, reflecting growing public interest despite the company’s recent profitability challenges. The lack of institutional investment could be a concern, as it often signifies lower confidence among larger investors regarding the company’s growth prospects. The consistent promoter holding suggests a commitment to the company, but the absence of institutional backing may limit access to capital for expansion or operational improvements. Overall, while the public interest is encouraging, the reliance on retail investors could pose risks if market sentiment shifts negatively.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies improve, Rana Sugars Ltd could potentially enhance its profitability and attract institutional investors. The company faces risks related to fluctuating raw material costs and market demand, which could impact its profitability and cash flow. Additionally, the relatively high cash conversion cycle indicates challenges in operational efficiency that need to be addressed. However, the stable promoter holding and increasing shareholder base suggest a foundation for future growth. If the company can enhance its operational performance and manage costs effectively, it may be positioned for a turnaround, potentially leading to improved financial metrics and market confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Rana Sugars Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Gayatri Sugars Ltd | 111 Cr. | 15.0 | 21.4/7.02 | 694 | 11.4 | 0.00 % | 36.6 % | % | 10.0 |
Dhampure Speciality Sugars Ltd | 71.6 Cr. | 85.9 | 142/82.0 | 23.2 | 41.0 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
Dhampur Bio Organics Ltd | 517 Cr. | 78.0 | 141/57.3 | 152 | 1.60 % | 3.97 % | 1.56 % | 10.0 | |
DCM Shriram Industries Ltd | 1,513 Cr. | 174 | 214/142 | 17.4 | 103 | 1.15 % | 13.7 % | 11.8 % | 2.00 |
Davangere Sugar Company Ltd | 496 Cr. | 3.47 | 12.9/3.03 | 43.9 | 2.45 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
Industry Average | 1,794.64 Cr | 265.39 | 53.38 | 229.21 | 0.65% | 8.62% | 7.89% | 6.37 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 427.36 | 378.05 | 370.45 | 451.62 | 499.94 | 340.13 | 337.16 | 415.39 | 462.04 | 385.57 | 390.35 | 474.84 | 530.90 |
Expenses | 404.09 | 370.28 | 345.69 | 394.09 | 467.05 | 344.75 | 318.90 | 379.14 | 442.53 | 393.39 | 370.54 | 435.28 | 523.99 |
Operating Profit | 23.27 | 7.77 | 24.76 | 57.53 | 32.89 | -4.62 | 18.26 | 36.25 | 19.51 | -7.82 | 19.81 | 39.56 | 6.91 |
OPM % | 5.45% | 2.06% | 6.68% | 12.74% | 6.58% | -1.36% | 5.42% | 8.73% | 4.22% | -2.03% | 5.07% | 8.33% | 1.30% |
Other Income | 8.94 | 4.44 | 0.55 | 9.47 | 3.68 | 5.50 | 2.90 | 5.82 | 3.33 | 1.79 | 8.78 | 19.87 | 8.14 |
Interest | 4.94 | 4.38 | 3.71 | 9.88 | 7.90 | 5.63 | 5.48 | 9.36 | 10.69 | 7.40 | 6.27 | 9.24 | 9.87 |
Depreciation | 7.49 | 6.98 | 7.47 | 9.40 | 7.83 | 8.33 | 8.22 | 10.96 | 9.24 | 9.09 | -1.48 | 10.26 | 9.12 |
Profit before tax | 19.78 | 0.85 | 14.13 | 47.72 | 20.84 | -13.08 | 7.46 | 21.75 | 2.91 | -22.52 | 23.80 | 39.93 | -3.94 |
Tax % | 21.03% | 0.00% | 88.89% | 4.92% | 26.25% | 11.62% | 26.27% | 0.28% | 34.71% | -34.37% | 40.29% | 0.33% | -35.79% |
Net Profit | 15.63 | 0.84 | 1.57 | 45.36 | 15.37 | -14.60 | 5.50 | 21.70 | 1.90 | -14.78 | 14.20 | 39.80 | -2.53 |
EPS in Rs | 1.02 | 0.05 | 0.10 | 2.95 | 1.00 | -0.95 | 0.36 | 1.41 | 0.12 | -0.96 | 0.92 | 2.59 | -0.16 |
Last Updated: August 20, 2025, 4:40 am
Below is a detailed analysis of the quarterly data for Rana Sugars Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 530.90 Cr.. The value appears strong and on an upward trend. It has increased from 474.84 Cr. (Mar 2025) to 530.90 Cr., marking an increase of 56.06 Cr..
- For Expenses, as of Jun 2025, the value is 523.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 435.28 Cr. (Mar 2025) to 523.99 Cr., marking an increase of 88.71 Cr..
- For Operating Profit, as of Jun 2025, the value is 6.91 Cr.. The value appears to be declining and may need further review. It has decreased from 39.56 Cr. (Mar 2025) to 6.91 Cr., marking a decrease of 32.65 Cr..
- For OPM %, as of Jun 2025, the value is 1.30%. The value appears to be declining and may need further review. It has decreased from 8.33% (Mar 2025) to 1.30%, marking a decrease of 7.03%.
- For Other Income, as of Jun 2025, the value is 8.14 Cr.. The value appears to be declining and may need further review. It has decreased from 19.87 Cr. (Mar 2025) to 8.14 Cr., marking a decrease of 11.73 Cr..
- For Interest, as of Jun 2025, the value is 9.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.24 Cr. (Mar 2025) to 9.87 Cr., marking an increase of 0.63 Cr..
- For Depreciation, as of Jun 2025, the value is 9.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.26 Cr. (Mar 2025) to 9.12 Cr., marking a decrease of 1.14 Cr..
- For Profit before tax, as of Jun 2025, the value is -3.94 Cr.. The value appears to be declining and may need further review. It has decreased from 39.93 Cr. (Mar 2025) to -3.94 Cr., marking a decrease of 43.87 Cr..
- For Tax %, as of Jun 2025, the value is -35.79%. The value appears to be improving (decreasing) as expected. It has decreased from 0.33% (Mar 2025) to -35.79%, marking a decrease of 36.12%.
- For Net Profit, as of Jun 2025, the value is -2.53 Cr.. The value appears to be declining and may need further review. It has decreased from 39.80 Cr. (Mar 2025) to -2.53 Cr., marking a decrease of 42.33 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.16. The value appears to be declining and may need further review. It has decreased from 2.59 (Mar 2025) to -0.16, marking a decrease of 2.75.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:34 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 648 | 698 | 856 | 1,091 | 977 | 1,092 | 1,313 | 1,222 | 1,400 | 1,627 | 1,593 | 1,713 | 1,782 |
Expenses | 564 | 674 | 717 | 1,012 | 940 | 1,049 | 1,229 | 1,095 | 1,222 | 1,511 | 1,506 | 1,638 | 1,723 |
Operating Profit | 84 | 24 | 139 | 79 | 37 | 42 | 84 | 126 | 178 | 116 | 87 | 75 | 58 |
OPM % | 13% | 3% | 16% | 7% | 4% | 4% | 6% | 10% | 13% | 7% | 5% | 4% | 3% |
Other Income | -0 | 8 | 1 | 2 | 7 | 15 | 231 | 77 | -13 | 21 | 14 | 30 | 39 |
Interest | 80 | 87 | 95 | 90 | 99 | 94 | 22 | 18 | 29 | 23 | 28 | 34 | 33 |
Depreciation | 33 | 27 | 28 | 28 | 31 | 33 | 34 | 27 | 28 | 31 | 35 | 27 | 27 |
Profit before tax | -30 | -82 | 17 | -38 | -87 | -69 | 259 | 158 | 109 | 82 | 37 | 44 | 37 |
Tax % | -19% | -33% | -0% | 19% | -1% | 8% | -3% | -0% | 22% | 23% | 24% | 22% | |
Net Profit | -24 | -55 | 17 | -45 | -86 | -75 | 266 | 158 | 85 | 63 | 28 | 34 | 37 |
EPS in Rs | -1.56 | -3.58 | 1.09 | -2.94 | -5.63 | -4.88 | 17.30 | 10.27 | 5.55 | 4.13 | 1.82 | 2.24 | 2.39 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -129.17% | 130.91% | -364.71% | -91.11% | 12.79% | 454.67% | -40.60% | -46.20% | -25.88% | -55.56% | 21.43% |
Change in YoY Net Profit Growth (%) | 0.00% | 260.08% | -495.61% | 273.59% | 103.90% | 441.88% | -495.27% | -5.60% | 20.32% | -29.67% | 76.98% |
Rana Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 5% |
3 Years: | 7% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 10% |
5 Years: | -4% |
3 Years: | -30% |
TTM: | 153% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 18% |
3 Years: | -17% |
1 Year: | -33% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 8% |
Last Year: | 6% |
Last Updated: September 5, 2025, 1:00 pm
Balance Sheet
Last Updated: October 10, 2025, 2:50 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 |
Reserves | 43 | -12 | 5 | -54 | -169 | -243 | 23 | 181 | 267 | 331 | 359 | 394 |
Borrowings | 810 | 824 | 864 | 841 | 865 | 874 | 303 | 207 | 222 | 412 | 443 | 435 |
Other Liabilities | 330 | 344 | 417 | 258 | 537 | 562 | 583 | 594 | 648 | 566 | 548 | 539 |
Total Liabilities | 1,336 | 1,310 | 1,440 | 1,199 | 1,387 | 1,346 | 1,064 | 1,136 | 1,290 | 1,462 | 1,503 | 1,522 |
Fixed Assets | 453 | 439 | 447 | 455 | 450 | 431 | 378 | 421 | 452 | 521 | 579 | 568 |
CWIP | 32 | 34 | 29 | 28 | 21 | 30 | 38 | 28 | 57 | 14 | 6 | 6 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Assets | 851 | 836 | 964 | 717 | 916 | 886 | 648 | 688 | 781 | 926 | 918 | 948 |
Total Assets | 1,336 | 1,310 | 1,440 | 1,199 | 1,387 | 1,346 | 1,064 | 1,136 | 1,290 | 1,462 | 1,503 | 1,522 |
Below is a detailed analysis of the balance sheet data for Rana Sugars Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 154.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 154.00 Cr..
- For Reserves, as of Mar 2025, the value is 394.00 Cr.. The value appears strong and on an upward trend. It has increased from 359.00 Cr. (Mar 2024) to 394.00 Cr., marking an increase of 35.00 Cr..
- For Borrowings, as of Mar 2025, the value is 435.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 443.00 Cr. (Mar 2024) to 435.00 Cr., marking a decrease of 8.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 539.00 Cr.. The value appears to be improving (decreasing). It has decreased from 548.00 Cr. (Mar 2024) to 539.00 Cr., marking a decrease of 9.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,522.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,503.00 Cr. (Mar 2024) to 1,522.00 Cr., marking an increase of 19.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 568.00 Cr.. The value appears to be declining and may need further review. It has decreased from 579.00 Cr. (Mar 2024) to 568.00 Cr., marking a decrease of 11.00 Cr..
- For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 948.00 Cr.. The value appears strong and on an upward trend. It has increased from 918.00 Cr. (Mar 2024) to 948.00 Cr., marking an increase of 30.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,522.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,503.00 Cr. (Mar 2024) to 1,522.00 Cr., marking an increase of 19.00 Cr..
However, the Borrowings (435.00 Cr.) are higher than the Reserves (394.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -726.00 | -800.00 | -725.00 | -762.00 | -828.00 | -832.00 | -219.00 | -81.00 | -44.00 | -296.00 | -356.00 | -360.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 33 | 30 | 32 | 24 | 52 | 46 | 40 | 41 | 28 | 29 | 32 | 46 |
Inventory Days | 516 | 387 | 401 | 168 | 231 | 207 | 104 | 151 | 196 | 180 | 176 | 156 |
Days Payable | 150 | 129 | 163 | 59 | 196 | 202 | 157 | 201 | 201 | 132 | 130 | 111 |
Cash Conversion Cycle | 399 | 288 | 270 | 133 | 88 | 51 | -12 | -9 | 23 | 77 | 78 | 91 |
Working Capital Days | -26 | -51 | -36 | -59 | -113 | -131 | -37 | -14 | 8 | 11 | 5 | 9 |
ROCE % | 5% | 1% | 11% | 5% | 1% | 3% | 9% | 20% | 26% | 13% | 7% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 2.24 | 1.82 | 4.13 | 5.55 | 10.27 |
Diluted EPS (Rs.) | 2.24 | 1.82 | 4.13 | 5.55 | 10.27 |
Cash EPS (Rs.) | 4.00 | 4.12 | 6.17 | 7.36 | 12.03 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 37.47 | 33.37 | 31.54 | 27.41 | 21.82 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 37.47 | 33.37 | 31.54 | 27.41 | 21.82 |
Revenue From Operations / Share (Rs.) | 111.55 | 103.73 | 106.00 | 91.20 | 79.59 |
PBDIT / Share (Rs.) | 6.83 | 6.56 | 8.90 | 11.84 | 8.57 |
PBIT / Share (Rs.) | 5.06 | 4.25 | 6.86 | 10.03 | 6.81 |
PBT / Share (Rs.) | 2.87 | 2.41 | 5.37 | 7.10 | 10.26 |
Net Profit / Share (Rs.) | 2.24 | 1.82 | 4.13 | 5.55 | 10.27 |
PBDIT Margin (%) | 6.12 | 6.32 | 8.40 | 12.97 | 10.76 |
PBIT Margin (%) | 4.53 | 4.10 | 6.47 | 10.99 | 8.55 |
PBT Margin (%) | 2.57 | 2.32 | 5.06 | 7.78 | 12.89 |
Net Profit Margin (%) | 2.00 | 1.75 | 3.89 | 6.08 | 12.90 |
Return on Networth / Equity (%) | 5.97 | 5.45 | 13.09 | 20.24 | 47.07 |
Return on Capital Employeed (%) | 10.72 | 9.41 | 15.36 | 25.29 | 21.67 |
Return On Assets (%) | 2.25 | 1.86 | 4.33 | 6.60 | 13.87 |
Long Term Debt / Equity (X) | 0.15 | 0.13 | 0.18 | 0.22 | 0.27 |
Total Debt / Equity (X) | 0.68 | 0.73 | 0.72 | 0.39 | 0.47 |
Asset Turnover Ratio (%) | 1.13 | 1.07 | 1.18 | 1.15 | 1.11 |
Current Ratio (X) | 1.12 | 1.07 | 1.11 | 1.11 | 1.05 |
Quick Ratio (X) | 0.40 | 0.33 | 0.35 | 0.35 | 0.47 |
Inventory Turnover Ratio (X) | 2.20 | 2.04 | 2.33 | 2.53 | 2.94 |
Interest Coverage Ratio (X) | 3.12 | 3.55 | 5.97 | 6.30 | 7.15 |
Interest Coverage Ratio (Post Tax) (X) | 2.02 | 1.99 | 3.77 | 4.52 | 5.69 |
Enterprise Value (Cr.) | 528.84 | 668.18 | 681.88 | 585.60 | 249.95 |
EV / Net Operating Revenue (X) | 0.30 | 0.41 | 0.41 | 0.41 | 0.20 |
EV / EBITDA (X) | 5.04 | 6.64 | 4.99 | 3.22 | 1.90 |
MarketCap / Net Operating Revenue (X) | 0.10 | 0.18 | 0.20 | 0.31 | 0.12 |
Price / BV (X) | 0.32 | 0.57 | 0.69 | 1.04 | 0.44 |
Price / Net Operating Revenue (X) | 0.10 | 0.18 | 0.20 | 0.31 | 0.12 |
EarningsYield | 0.18 | 0.09 | 0.18 | 0.19 | 1.07 |
After reviewing the key financial ratios for Rana Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.00. This value is within the healthy range. It has decreased from 4.12 (Mar 24) to 4.00, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 37.47. It has increased from 33.37 (Mar 24) to 37.47, marking an increase of 4.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 37.47. It has increased from 33.37 (Mar 24) to 37.47, marking an increase of 4.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 111.55. It has increased from 103.73 (Mar 24) to 111.55, marking an increase of 7.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.83. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 6.83, marking an increase of 0.27.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.06. This value is within the healthy range. It has increased from 4.25 (Mar 24) to 5.06, marking an increase of 0.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.87. This value is within the healthy range. It has increased from 2.41 (Mar 24) to 2.87, marking an increase of 0.46.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.24. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
- For PBDIT Margin (%), as of Mar 25, the value is 6.12. This value is below the healthy minimum of 10. It has decreased from 6.32 (Mar 24) to 6.12, marking a decrease of 0.20.
- For PBIT Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 10. It has increased from 4.10 (Mar 24) to 4.53, marking an increase of 0.43.
- For PBT Margin (%), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 10. It has increased from 2.32 (Mar 24) to 2.57, marking an increase of 0.25.
- For Net Profit Margin (%), as of Mar 25, the value is 2.00. This value is below the healthy minimum of 5. It has increased from 1.75 (Mar 24) to 2.00, marking an increase of 0.25.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.97. This value is below the healthy minimum of 15. It has increased from 5.45 (Mar 24) to 5.97, marking an increase of 0.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.72. This value is within the healthy range. It has increased from 9.41 (Mar 24) to 10.72, marking an increase of 1.31.
- For Return On Assets (%), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. It has increased from 1.86 (Mar 24) to 2.25, marking an increase of 0.39.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.13 (Mar 24) to 0.15, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has decreased from 0.73 (Mar 24) to 0.68, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.13. It has increased from 1.07 (Mar 24) to 1.13, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has increased from 1.07 (Mar 24) to 1.12, marking an increase of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.33 (Mar 24) to 0.40, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 4. It has increased from 2.04 (Mar 24) to 2.20, marking an increase of 0.16.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.12. This value is within the healthy range. It has decreased from 3.55 (Mar 24) to 3.12, marking a decrease of 0.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. It has increased from 1.99 (Mar 24) to 2.02, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 528.84. It has decreased from 668.18 (Mar 24) to 528.84, marking a decrease of 139.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 24) to 0.30, marking a decrease of 0.11.
- For EV / EBITDA (X), as of Mar 25, the value is 5.04. This value is within the healthy range. It has decreased from 6.64 (Mar 24) to 5.04, marking a decrease of 1.60.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
- For Price / BV (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has decreased from 0.57 (Mar 24) to 0.32, marking a decrease of 0.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
- For EarningsYield, as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.18, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rana Sugars Ltd:
- Net Profit Margin: 2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.72% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.97% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.4
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 5.98 (Industry average Stock P/E: 53.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.68
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Sugar | SCO 49-50, Sector 8-C, Chandigarh Chandigarh 160009 | info@ranagroup.com http://www.ranasugars.com |
Management | |
---|---|
Name | Position Held |
Mr. Rana Ranjit Singh | Chairman & Non-Exe.Director |
Mr. Rana Veer Pratap Singh | Managing Director |
Mr. Surjeet Kaushal | Ind. Non-Executive Director |
Ms. Navpreet Kaur | Ind. Non-Executive Director |
Mr. Harneet Singh Oberoi | Ind. Non-Executive Director |
Mr. Basant Kumar Bajaj | Independent Director |
FAQ
What is the intrinsic value of Rana Sugars Ltd?
Rana Sugars Ltd's intrinsic value (as of 19 October 2025) is 10.41 which is 27.20% lower the current market price of 14.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 219 Cr. market cap, FY2025-2026 high/low of 21.8/11.1, reserves of ₹394 Cr, and liabilities of 1,522 Cr.
What is the Market Cap of Rana Sugars Ltd?
The Market Cap of Rana Sugars Ltd is 219 Cr..
What is the current Stock Price of Rana Sugars Ltd as on 19 October 2025?
The current stock price of Rana Sugars Ltd as on 19 October 2025 is 14.3.
What is the High / Low of Rana Sugars Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rana Sugars Ltd stocks is 21.8/11.1.
What is the Stock P/E of Rana Sugars Ltd?
The Stock P/E of Rana Sugars Ltd is 5.98.
What is the Book Value of Rana Sugars Ltd?
The Book Value of Rana Sugars Ltd is 35.6.
What is the Dividend Yield of Rana Sugars Ltd?
The Dividend Yield of Rana Sugars Ltd is 0.00 %.
What is the ROCE of Rana Sugars Ltd?
The ROCE of Rana Sugars Ltd is 7.67 %.
What is the ROE of Rana Sugars Ltd?
The ROE of Rana Sugars Ltd is 5.99 %.
What is the Face Value of Rana Sugars Ltd?
The Face Value of Rana Sugars Ltd is 10.0.